Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

Impact of the influenza vaccine on COVID-19 infection rates and severity

(2021) Anna Conlon et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Performance of SARS-CoV-2 serology tests: Are they good enough?

(2021) Isabelle Piec et al.   PLoS One

Immunology of COVID-19: current state of the science

(2020) Nicolas Vabret et al.   IMMUNITY

The Role of Antibody Testing for SARS-CoV-2: Is There One?

(2020) Elitza S. Theel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries

(2020) Joaquim Mullol et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID‐19 deaths in Italy

(2020) Daniela Marín‐Hernández et al.   JOURNAL OF MEDICAL VIROLOGY

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

(2020) Xin Xu et al.   NATURE MEDICINE

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

(2020) A. Rostami et al.   CLINICAL MICROBIOLOGY AND INFECTION

Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review

(2020) Chih-Cheng Lai et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Substantial underestimation of SARS-CoV-2 infection in the United States

(2020) Sean L. Wu et al.   Nature Communications

Are we underestimating seroprevalence of SARS-CoV-2?

(2020) Stephen Burgess et al.   BMJ-British Medical Journal

Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients

(2020) Huan Han et al.   mSphere